Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment
暂无分享,去创建一个
M. Haris | Sheema Hashem | A. Bhat | S. Nisar | Rakesh Kumar | Deepika Mishra | T. Masoodi | N. Wani | M. Macha | Mayank Singh | Geetanjali Sageena | Parvaiz Yousuf | Sabah Nisar
[1] S. Batra,et al. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy , 2021, Signal Transduction and Targeted Therapy.
[2] Liping Wang,et al. Roles of IFN-γ in tumor progression and regression: a review , 2020, Biomarker research.
[3] A. Birbrair,et al. Pericyte in Oral Squamous Cell Carcinoma: A Systematic Review , 2020, Head and Neck Pathology.
[4] A. Green,et al. Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy , 2020, Frontiers in Cell and Developmental Biology.
[5] Xi Yang,et al. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway , 2020, Cell Death & Disease.
[6] A. Argiris,et al. An update on angiogenesis targeting in head and neck squamous cell carcinoma , 2020, Cancers of the Head & Neck.
[7] K. Schenke-Layland,et al. The role of extracellular matrix in biomechanics and its impact on bioengineering of cells and 3D tissues. , 2019, Matrix biology : journal of the International Society for Matrix Biology.
[8] Nayoung Kim,et al. CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling , 2019, Scientific Reports.
[9] J. Bagan,et al. Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy , 2019, Journal of clinical and experimental dentistry.
[10] P. Friedlander,et al. Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways. , 2019, International journal of oncology.
[11] J. Schlom,et al. Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors , 2019, Journal of Immunotherapy for Cancer.
[12] Li‐Wha Wu,et al. Cancer‐associated fibroblast‐derived interleukin‐1β activates protumor C‐C motif chemokine ligand 22 signaling in head and neck cancer , 2019, Cancer science.
[13] M. Gulubova,et al. IL-6 Activities in the Tumour Microenvironment. Part 1 , 2019, Open access Macedonian journal of medical sciences.
[14] M. Montès,et al. New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments , 2019, Theranostics.
[15] J. Masumoto,et al. The role of interleukin-1 in general pathology , 2019, Inflammation and regeneration.
[16] B. Mroczko,et al. Clinical Significance of Selected Chemokines in Thyroid Cancer , 2019, AntiCancer Research.
[17] Michael Korrer,et al. Phenotypical and functional analysis of natural killer cells from primary human head and neck squamous cell carcinomas , 2019, The Journal of Immunology.
[18] M. Ergin,et al. Role of T-helper 17 cell related cytokines in laryngeal cancer , 2019, The Journal of Laryngology & Otology.
[19] Yan Cui,et al. Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy , 2019, Front. Cell Dev. Biol..
[20] P. Kubes,et al. The Neutrophil's Role During Health and Disease. , 2019, Physiological reviews.
[21] M. Masařík,et al. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review , 2019, Molecular Cancer.
[22] C. R. Leemans,et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial , 2019, The Lancet.
[23] B. Molon,et al. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization , 2018, International journal of molecular sciences.
[24] Ge Zhou,et al. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma , 2018, British Journal of Cancer.
[25] pYuChun Linp. Cancer-associated fibroblast induced chemokine (C-C motif) ligand 11 contribute to the progression of head and neck cancer , 2018 .
[26] Lun Zhang,et al. TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions. , 2018, Cancer letters.
[27] Y. Hwang,et al. IL-1β Induces Fascin Expression and Increases Cancer Invasion , 2018, AntiCancer Research.
[28] W. Wen,et al. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis , 2018, Cancer Immunology, Immunotherapy.
[29] H. J. Lee,et al. Chemokine receptor CXCR7 expression, function and clinical implications in head and neck squamous cell carcinoma. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] R. Eri,et al. Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer , 2018, Medicina.
[31] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[32] F. Ihara,et al. Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer , 2018, Front. Immunol..
[33] Mihir B. Patel,et al. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma , 2018, Head and Neck Pathology.
[34] Jenq-Lin Yang,et al. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases , 2018, Cellular Physiology and Biochemistry.
[35] Xin-hua Liang,et al. Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses. , 2018, Oncology letters.
[36] K. Ishibashi,et al. Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , 2018, Oncoimmunology.
[37] Zachary T. Giaccone,et al. IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. , 2018, Cancer research.
[38] D. Laouini,et al. Role of Human Macrophage Polarization in Inflammation during Infectious Diseases , 2018, International journal of molecular sciences.
[39] M. Kaplan,et al. IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers , 2018, OncoTargets and therapy.
[40] G. Paludetti,et al. IFN-γ and other serum cytokines in head and neck squamous cell carcinomas. , 2018, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.
[41] Wei Liu,et al. TGF-β1/TβRII/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages. , 2018, Biochemical and biophysical research communications.
[42] T. Yoshimura. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? , 2018, Cellular & Molecular Immunology.
[43] Ge Zhou,et al. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma , 2018, British Journal of Cancer.
[44] Manish R. Patel,et al. A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors , 2017, Clinical Cancer Research.
[45] Xiqiang Liu,et al. Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma , 2017, International journal of molecular medicine.
[46] D. Loew,et al. Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane , 2017, Nature Communications.
[47] V. Budach,et al. SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy , 2017, Clinical and translational radiation oncology.
[48] A. Kulkarni,et al. STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC , 2017, Journal of dental research.
[49] L. Pignataro,et al. T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma , 2017, Oncoimmunology.
[50] Ling-Feng Wang,et al. IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC , 2017, Oncotarget.
[51] P. Hammerman,et al. Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck. , 2017, Oral oncology.
[52] K. Shen,et al. Recent progress in GM-CSF-based cancer immunotherapy. , 2017, Immunotherapy.
[53] A. Santoni,et al. Role of Distinct Natural Killer Cell Subsets in Anticancer Response , 2017, Front. Immunol..
[54] I. Zaletel,et al. Serum cytokine profile of laryngeal squamous cell carcinoma patients , 2017, The Journal of Laryngology & Otology.
[55] Tieshan Teng,et al. Neutrophils and Immunity: From Bactericidal Action to Being Conquered , 2017, Journal of immunology research.
[56] T. Oyama,et al. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages , 2016, Oncotarget.
[57] X. Cong,et al. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway , 2016, Oncotarget.
[58] Hui-min Li,et al. CCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma , 2016, Oncotarget.
[59] K. Gibson-Corley,et al. Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma , 2016, Oncotarget.
[60] Anping Li,et al. The CXCL8-CXCR1/2 pathways in cancer , 2016, Cytokine & growth factor reviews.
[61] R. Kalluri. The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.
[62] Ling-Feng Wang,et al. IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway , 2016, Oncotarget.
[63] G. Liao,et al. TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[64] M. Quer,et al. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma , 2016, European Archives of Oto-Rhino-Laryngology.
[65] T. Teknos,et al. Interleukin-6 role in head and neck squamous cell carcinoma progression , 2016, World journal of otorhinolaryngology - head and neck surgery.
[66] A. Goy,et al. Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies , 2016, Oncotarget.
[67] Y. Okamoto,et al. Invariant NKT cells are resistant to circulating CD15+ myeloid‐derived suppressor cells in patients with head and neck cancer , 2016, Cancer science.
[68] Juan Wang,et al. Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis , 2016, Scientific Reports.
[69] M. Goldring,et al. Laminins and Nidogens in the Pericellular Matrix of Chondrocytes: Their Role in Osteoarthritis and Chondrogenic Differentiation. , 2016, The American journal of pathology.
[70] H. Worthington,et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. , 2015, The Cochrane database of systematic reviews.
[71] Seong-Jin Kim,et al. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer , 2015, Oncotarget.
[72] M. Quer,et al. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma , 2015, Oncotarget.
[73] P. Lin,et al. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer , 2015, Oncotarget.
[74] J. Pollard,et al. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer , 2015, Pharmacological research.
[75] R. Puri,et al. Targeting of IL-4 and IL-13 receptors for cancer therapy. , 2015, Cytokine.
[76] Ayyaz Ali Khan,et al. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients , 2015, Cancer investigation.
[77] C. Chen,et al. IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer , 2015, Journal of cellular physiology.
[78] G. Hu,et al. New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.
[79] F. J. Ahmad,et al. Role of neurotransmitter Substance P in progression of oral squamous cell carcinoma. , 2015, Pathology, research and practice.
[80] M. S. St John. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma , 2015, The Laryngoscope.
[81] Liyu Liu,et al. Enhanced Invasion of Metastatic Cancer Cells via Extracellular Matrix Interface , 2015, PloS one.
[82] Maie A. John. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma. , 2015 .
[83] Fa-Yu Liu,et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. , 2014, International journal of oncology.
[84] S. Kondo,et al. Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue. , 2014, Auris, nasus, larynx.
[85] I. Herman,et al. Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics. , 2014, American journal of physiology. Cell physiology.
[86] D. Pennington,et al. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.
[87] L. Bingle,et al. The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[88] K. Mills,et al. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines , 2014, Oncogene.
[89] F. Giancotti. Deregulation of cell signaling in cancer , 2014, FEBS letters.
[90] Changfu Sun,et al. Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9. , 2014, Oncology reports.
[91] Å. Borg,et al. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. , 2014, Cancer research.
[92] Xia Li,et al. A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma. , 2014, Carcinogenesis.
[93] T. Andersson,et al. Interleukin‐6 drives melanoma cell motility through p38α‐MAPK‐dependent up‐regulation of WNT5A expression , 2014, Molecular oncology.
[94] T. Omori,et al. CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma , 2014, BMC Cancer.
[95] M. Young,et al. Effect of the Premalignant and Tumor Microenvironment on Immune Cell Cytokine Production in Head and Neck Cancer , 2014, Cancers.
[96] Hau-Ren Chen,et al. Monocyte Chemotactic Protein 1 (MCP-1) Modulates Pro-Survival Signaling to Promote Progression of Head and Neck Squamous Cell Carcinoma , 2014, PloS one.
[97] Kai-Ping Chang,et al. Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma , 2013, PloS one.
[98] P. Bragado,et al. TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling , 2013, Nature Cell Biology.
[99] Yaoh-Shiang Lin,et al. The paracrine effect of cancer‐associated fibroblast‐induced interleukin‐33 regulates the invasiveness of head and neck squamous cell carcinoma , 2013, The Journal of pathology.
[100] S. Koul,et al. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. , 2013, Genes & cancer.
[101] D. Waugh,et al. Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer , 2013, Pharmaceuticals.
[102] Kai-Ping Chang,et al. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma. , 2013, Oral oncology.
[103] C. Garlanda,et al. Tumor associated macrophages and neutrophils in tumor progression , 2013, Journal of cellular physiology.
[104] P. Xie,et al. M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway , 2013, Laboratory Investigation.
[105] C. Umbreit,et al. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma. , 2013, Oncology reports.
[106] Wei Liu,et al. Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion , 2013, PloS one.
[107] R. Shruthy,et al. Immunohistochemical expression of basement membrane laminin in histological grades of oral squamous cell carcinoma: A semiquantitative analysis , 2013, Journal of oral and maxillofacial pathology : JOMFP.
[108] M. Smyth,et al. Molecular mechanisms of natural killer cell activation in response to cellular stress , 2013, Cell Death and Differentiation.
[109] Pankaj Agarwal,et al. Expression of type IV collagen in different histological grades of oral squamous cell carcinoma: an immunohistochemical study. , 2013, Journal of cancer research and therapeutics.
[110] R. McLendon,et al. Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.
[111] M. Muñoz,et al. The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists , 2012, Peptides.
[112] C. Chung,et al. Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy , 2012, Molecular Cancer Therapeutics.
[113] S. Amin,et al. Ah Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype , 2012, Molecular Cancer Research.
[114] D. Conrad,et al. Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity , 2012, The Journal of Immunology.
[115] M. Fischer,et al. New vessel formation in peritumoral area of squamous cell carcinoma of the head and neck , 2012, Head & neck.
[116] Katsumasa Takahashi,et al. Immunosuppressive activity of CD14+ HLA‐DR− cells in squamous cell carcinoma of the head and neck , 2012, Cancer science.
[117] Christian Freudlsperger,et al. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers , 2012, Oncogene.
[118] S-F Yang,et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. , 2012, Oral diseases.
[119] Yun Hong,et al. Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions , 2012, Mediators of inflammation.
[120] A. Egloff,et al. Chemokine Receptor 7 (CCR7) Gene Expression Is Regulated by NF-κB and Activator Protein 1 (AP1) in Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)* , 2011, The Journal of Biological Chemistry.
[121] I. Wistuba,et al. STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma , 2011, Clinical Cancer Research.
[122] J. Datta,et al. IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway , 2011, Molecular Cancer Research.
[123] T. Whiteside,et al. Tumor‐derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation , 2011, International journal of cancer.
[124] E. Crivellato,et al. The role of pericytes in angiogenesis. , 2011, The International journal of developmental biology.
[125] S. Quezada,et al. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication , 2011, Immunological reviews.
[126] C. Akdis,et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. , 2011, The Journal of allergy and clinical immunology.
[127] D. Bernabé,et al. Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells , 2011, Brain, Behavior, and Immunity.
[128] K. Harrington,et al. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. , 2011, European journal of cancer.
[129] T. Yen,et al. Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis. , 2011, Oral oncology.
[130] S. Malkoski,et al. TGFβ signaling in head and neck squamous cell carcinoma , 2010, Oncogene.
[131] Changfu Sun,et al. The chemokine receptor 7 regulates cell adhesion and migration via beta1 integrin in metastatic squamous cell carcinoma of the head and neck. , 2010, Oncology reports.
[132] R. Gladue,et al. CCR1 antagonists: what have we learned from clinical trials. , 2010, Current topics in medicinal chemistry.
[133] Darren R. Williams,et al. Tumor‐stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7 , 2010, International journal of cancer.
[134] Catherine C. Park,et al. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. , 2010, Cancer research.
[135] C. Murdoch,et al. Functional expression of the chemokine receptor XCR1 on oral epithelial cells , 2010, The Journal of pathology.
[136] Kristian Pietras,et al. Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.
[137] J. Steinke,et al. Immunologic messenger molecules: cytokines, interferons, and chemokines. , 2010, The Journal of allergy and clinical immunology.
[138] T. Nokes,et al. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics , 2009, Thrombosis and Haemostasis.
[139] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[140] Shun-Fa Yang,et al. Contribution of genetic polymorphisms of stromal cell–derived factor‐1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer , 2009, Head & neck.
[141] L. J. Eldik,et al. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes , 2009, Brain Research.
[142] Y. Oike,et al. Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma , 2009, Clinical Cancer Research.
[143] J. Chuang,et al. CCL5/CCR5 axis promotes the motility of human oral cancer cells , 2009, Journal of cellular physiology.
[144] Z. Shang,et al. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma. , 2009, Oral oncology.
[145] F. Esteban,et al. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. , 2009, Anticancer research.
[146] Panomwat Amornphimoltham,et al. Tumor–stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells , 2009, Cell biology international.
[147] Z. Shang,et al. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[148] C. Gleissner,et al. Platelet Chemokines in Vascular Disease , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[149] Yong Lin,et al. Tumor necrosis factor and cancer, buddies or foes? , 2008, Acta Pharmacologica Sinica.
[150] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[151] M. Brown,et al. NF-κB in carcinoma therapy and prevention , 2008 .
[152] E. Prakash,et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. , 2008, Carcinogenesis.
[153] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[154] S. Vandenberg,et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.
[155] J. Nör,et al. Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. , 2008, Neoplasia.
[156] P. Cohen,et al. IL-1β-stimulated activation of ERK1/2 and p38α MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-α in HeLa cells , 2008 .
[157] F. Autschbach,et al. Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity1 , 2007, The Journal of Immunology.
[158] F. Cunha,et al. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense. , 2007, Oncology reports.
[159] R. Strieter,et al. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. , 2007, Cancer research.
[160] J. Siegfried,et al. Multiple Cytokine and Growth Factor Serum Biomarkers Predict Therapeutic Response and Survival in Advanced-Stage Head and Neck Cancer Patients , 2007, Clinical Cancer Research.
[161] S. Zheng,et al. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells1 , 2007, The Journal of Immunology.
[162] Faina Linkov,et al. Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling , 2007, Cancer Epidemiology Biomarkers & Prevention.
[163] Paolo P. Provenzano,et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.
[164] B. Han,et al. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? , 2006, Cancer and Metastasis Reviews.
[165] P. Hwu,et al. Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms , 2006, Clinical Cancer Research.
[166] A. Ziober,et al. The extracellular matrix in oral squamous cell carcinoma: Friend or foe? , 2006, Head & neck.
[167] C. Snyderman,et al. Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapy , 2006, International journal of cancer.
[168] T. Salo,et al. Collagen XVII promotes integrin-mediated squamous cell carcinoma transmigration--a novel role for alphaIIb integrin and tirofiban. , 2006, Experimental cell research.
[169] W. A. Yeudall,et al. Down-regulation of CXCL5 inhibits squamous carcinogenesis. , 2006, Cancer research.
[170] M. Burdick,et al. Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.
[171] S. Fujieda,et al. Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. , 2006, Auris, nasus, larynx.
[172] M. Burdick,et al. CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.
[173] Steven Song,et al. The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.
[174] C. Van Waes,et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma , 2005, Head & neck.
[175] T. Giordano,et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.
[176] Shaomeng Wang,et al. Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. , 2005, Cancer research.
[177] D. Landsittel,et al. Multiplexed Analysis of Serum Cytokines as Biomarkers in Squamous Cell Carcinoma of the Head and Neck Patients , 2005, The Laryngoscope.
[178] C. Pothoulakis,et al. Metalloproteinases and Transforming Growth Factor-α Mediate Substance P-induced Mitogen-activated Protein Kinase Activation and Proliferation in Human Colonocytes* , 2004, Journal of Biological Chemistry.
[179] S. Zucker,et al. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. , 2004, Cancer letters.
[180] E. Oldfield,et al. Human Platelet Dense Granules Contain Polyphosphate and Are Similar to Acidocalcisomes of Bacteria and Unicellular Eukaryotes* , 2004, Journal of Biological Chemistry.
[181] R. Moll,et al. CD34+ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx , 2004, Virchows Archiv.
[182] J. Siegfried,et al. Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells , 2003, Journal of Neuroimmunology.
[183] H. Yoshida,et al. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. , 2003, Experimental cell research.
[184] Holger Gerhardt,et al. Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.
[185] M. Ratajczak,et al. CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion , 2003, Journal of Molecular Histology.
[186] Calman Prussin,et al. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[187] J. Steinke,et al. 2. Cytokines and chemokines. , 2003, The Journal of allergy and clinical immunology.
[188] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[189] A. Enk,et al. Immature, but not inactive: the tolerogenic function of immature dendritic cells , 2002, Immunology and cell biology.
[190] M. Wadhwa,et al. Chemokine/chemokine receptor nomenclature. , 2002, Journal of immunological methods.
[191] Gerold Schuler,et al. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? , 2002, Trends in immunology.
[192] B. Mian,et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. , 2002, The American journal of pathology.
[193] P. Dhawan,et al. Role of CXCL1 in tumorigenesis of melanoma , 2002, Journal of leukocyte biology.
[194] F. Balkwill,et al. The role of cytokines in the epithelial cancer microenvironment. , 2002, Seminars in cancer biology.
[195] B. H. Shah,et al. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. , 2001, Experimental & Molecular Medicine.
[196] Michel C. Nussenzweig,et al. Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.
[197] J. Cruse,et al. 10 - Cytokines and Chemokines , 2004 .
[198] D J Mooney,et al. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. , 2001, Cancer research.
[199] T. Tlsty,et al. Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.
[200] M. Levite. Nerve‐Driven Immunity: The Direct Effects of Neurotransmitters on T‐Cell Function , 2000, Annals of the New York Academy of Sciences.
[201] H. Nakshatri,et al. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. , 1999, Biochemical and biophysical research communications.
[202] D. Mooney,et al. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. , 1999, The American journal of pathology.
[203] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[204] M. Young,et al. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells , 1997, International journal of cancer.
[205] D. Kreutzer,et al. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. , 1997, American journal of surgery.
[206] M. Shurin. Dendritic cells presenting tumor antigen , 1996, Cancer Immunology, Immunotherapy.
[207] J. Faivre,et al. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[208] P. Reade,et al. The prognosis of oral mucosal squamous cell carcinomas: a comparison of clinical and histopathological grading and of laminin and type IV collagen staining. , 1996, Australian dental journal.
[209] M J Metzelaar,et al. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. , 1991, The Journal of biological chemistry.
[210] D. Winn,et al. Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.
[211] P. Singh,et al. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. , 1986, Cellular immunology.
[212] A. Le,et al. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells. , 2018, Advances in experimental medicine and biology.
[213] V. Weaver,et al. The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate. , 2018, Current topics in developmental biology.
[214] Muhammad Sohail Zafar,et al. Role of Salivary Biomarkers in Oral Cancer Detection. , 2018, Advances in clinical chemistry.
[215] G. Wolf,et al. Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. , 2015, Oral oncology.
[216] Patrice Ravel,et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. , 2013, Cancer research.
[217] S. Hunt,et al. Endothelin‐1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal–epithelial interactions , 2012, International journal of cancer.
[218] F. Levi-Schaffer,et al. Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. , 2012, Lung cancer.
[219] R. Ferris,et al. Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA. , 2012, Cancer research.
[220] A. Stepan,et al. VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis. , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[221] Yong Li,et al. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[222] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[223] S. Goodman,et al. Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas. , 2011, Experimental and therapeutic medicine.
[224] Ruud H. Brakenhoff,et al. The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.
[225] Fei Xing,et al. Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.
[226] A. Stepan,et al. Immunohistochemical characterization of tumoral vessels in oral squamous cell carcinoma. , 2008, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[227] M. Brown,et al. NF-kappaB in carcinoma therapy and prevention. , 2008, Expert opinion on therapeutic targets.
[228] P. Cohen,et al. IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. , 2008, Cellular signalling.
[229] R. Moll,et al. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. , 2004, Virchows Archiv : an international journal of pathology.
[230] M. Oka,et al. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential , 2004, Virchows Archiv.
[231] D. Metcalfe,et al. 4. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[232] M. Cameron,et al. Cytokines and chemokines--their receptors and their genes: an overview. , 2003, Advances in experimental medicine and biology.
[233] C. Muro-Cacho,et al. Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[234] A. S. Pak,et al. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.